Oral Presentation Clinical Oncology Society of Australia 2014 Annual Scientific Meeting

Targeted therapy for NSCLC 2015: second gen, third gen and beyond (#70)

Thomas Lynch 1
  1. Yale, New Haven, CONNE, United States

Details TBC